Blockbuster drugs : the rise and decline of the pharmaceutical industry
(Book)
Author
Published
New York : Oxford University Press, [2014].
Status
Central - Adult Nonfiction
338.476151 LI
1 available
338.476151 LI
1 available
Copies
Location | Call Number | Status |
---|---|---|
Central - Adult Nonfiction | 338.476151 LI | Available |
Description
Loading Description...
More Details
Published
New York : Oxford University Press, [2014].
Format
Book
Physical Desc
xii, 223 pages : illustrations ; 22 cm
Language
English
Notes
Bibliography
Includes bibliographical references and index.
Description
"This book uses the cases of several landmark drugs to discuss the history of the pharmaceutical industry, and discusses what could be next"--Provided by publisher.
Description
For the world's largest prescription drug manufacturers, the last few years have been a harrowing time. Recently, Pfizer's Lipitor, GlaxoSmithKline's Advair, AstraZeneca's Seroquel, and Sanofi-Aventis and Bristol-Myers Squibb's Plavix all came off patent in the crucial U.S. market. This so-called "patent cliff" meant hundreds of billions of dollars in lost revenue and has pharmaceutical developers scrambling to create new drugs and litigating to extend current patent protections. Having spent most of his career in drug discovery in "big pharma," Dr. Li now delivers an insider's account of how the drug industry ascended to its plateau and explores the nature of the turmoil it faces in the coming years. He begins with a survey of the landscape before "blockbuster drugs," and proceeds to describe how those drugs were discovered and subsequently became integral to the business models of large pharmaceutical companies. For example, in early 1980s, Tagamet, the first "blockbuster drug," transformed a minor Philadelphia-based drug maker named SmithKline & French into the world's ninth-largest pharmaceutical company in terms of sales. The project that delivered Tagamet was nearly terminated several times because research efforts begun in 1964 produced no apparent results within the first eleven years. Similar stories accompany the discovery and development of now-ubiquitous prescription drugs, among them Claritin, Prilosec, Nexium, Plavix, and Ambien. These stories, and the facets of the pharmaceutical industry that they reveal, can teach us valuable lessons and reveal many crucial aspects about the future landscape of drug discovery. As always, Dr. Li writes in a readable style and intersperses fascinating stories of scientific discovery with engaging human drama.
Subjects
LC Subjects
Also in this Series
Checking series information...
Reviews from GoodReads
Loading GoodReads Reviews.
Citations
APA Citation, 7th Edition (style guide)
Li, J. J. (2014). Blockbuster drugs: the rise and decline of the pharmaceutical industry . Oxford University Press.
Chicago / Turabian - Author Date Citation, 17th Edition (style guide)Li, Jie Jack. 2014. Blockbuster Drugs: The Rise and Decline of the Pharmaceutical Industry. Oxford University Press.
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)Li, Jie Jack. Blockbuster Drugs: The Rise and Decline of the Pharmaceutical Industry Oxford University Press, 2014.
MLA Citation, 9th Edition (style guide)Li, Jie Jack. Blockbuster Drugs: The Rise and Decline of the Pharmaceutical Industry Oxford University Press, 2014.
Note! Citations contain only title, author, edition, publisher, and year published. Citations should be used as a guideline and should be double checked for accuracy. Citation formats are based on standards as of August 2021.
Staff View
Loading Staff View.